Hybrid vs. Traditional Clinical Trial Costs
Source: Life Science Leader
By Industry Standard Research
In a recent survey about hybrid trials, over half of respondents reported that hybrid trials are currently more expensive to conduct compared to trials in the traditional model while only one-quarter considered hybrid trials to be less expensive than traditionally run trials. However, there is an expected flip in this sentiment. Two years from now, almost half of respondents expect the hybrid model to be less expensive while only about a quarter think that hybrid trials will be more expensive than traditional trials.
access the Magazine Article!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.
Subscribe to Life Science Leader
X
Subscribe to Life Science Leader
This website uses cookies to ensure you get the best experience on our website. Learn more